- Filed
- May 2, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 28.78M sh |
| Short Term Investments | Q1 2025 · Mar 30, 2025 | $122.12M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $122.25M |
| Current Liabilities | Q1 2025 · Mar 30, 2025 | $241.96M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $270.08M |
| Total Liabilities | Q1 2025 · Mar 30, 2025 | $279.95M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $309.16M |
| Current Assets | Q1 2025 · Mar 30, 2025 | $723.75M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $758.03M |
| Total Assets | Q1 2025 · Mar 30, 2025 | $814.2M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $850.23M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $286.44M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 29.4M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $11.44M |
| Capex | Q1 2025 · Mar 31, 2024 | $2.51M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $17.19M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $511.36M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $535.5M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.63 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.63 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $18.07M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $20.23M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$18.65M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$21.65M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $48.24M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $116.35M |
| Revenue | Q1 2025 · Mar 31, 2024 | $164.59M |